Busulfan with fludarabine myeloablative conditioning regimen in myeloid neoplasms: A single center experience.

被引：0
|
作者：
Raj, Renju V.
Button, Anna M.
Dozeman, Lindsay
De Magalhaes-Silverman, Margarida
机构：
[1] Univ Iowa, Iowa City, IA USA
[2] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e18000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18000
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Fludarabine and Melphalan Reduced Toxicity Versus a Myeloablative Fludarabine and Busulfan Conditioning Regimen for Acute Myeloid Leukemia
    Mathews, Vikram
    Kulkarni, Uday
    Selvarajan, Sushil
    Joshi, Nutan Damodar
    Fouzia
    Korula, Anu
    Lionel, Sharon Anbumalar
    Lakshmi, Kavitha M.
    Srivastava, Alok
    George, Biju
    Abraham, Aby
    BLOOD, 2023, 142
  • [2] Busulfan and Fludarabine As Conditioning Regimen for Unrelated Allogeneic Stem Cell Transplant: A Single-Center Experience
    Sutamtewagul, Grerk
    Abbi, Kamal Kant Singh
    Farooq, Umar
    Mott, Sarah L.
    Dozeman, Lindsay
    Silverman, Margarida
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S358 - S358
  • [3] Myeloablative busulfan with cyclophosphamide (BuCy) versus busulfan with fludarabine (BuFlu) in myeloid neoplasms.
    Raj, Renju V.
    Dozeman, Lindsay
    Button, Anna M.
    De Magalhaes-Silverman, Margarida
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Efficacy of treosulfan in combination with fludarabine as conditioning regimen in allogeneic transplantation as compared with a myeloablative conditioning using busulfan and fludarabine
    Calvo Sanchez, J. A.
    Fernandez Garcia, S.
    Aranguren del Castillo, L.
    Fernandez-Luis, S.
    Yanez San Segundo, L.
    Insunza Gaminde, A.
    Fernandez Escalada, N.
    Martin Sanchez, G.
    Colorado Araujo, M. M.
    Lopez Duarte, M.
    Sanchez Escamilla, M.
    Montes Gaisan, C.
    Romon Alonso, J. I.
    Arroyo Rodriguez, J. L.
    Ocio San Miguel, E. M.
    Bermudez Rodriguez, M. A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 166 - 167
  • [5] Fludarabine - Oral busulfan myeloablative conditioning for allogenic peripheral stem cell transplantation. A single center experience in Colombia
    Rosales, C.
    Abello, V.
    Rosales, E.
    Esguerra, H.
    Linares, A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 97 - 97
  • [6] Fludarabine and busulfan (FluBu regimen) as myeloablative conditioning regimen for allogeneic PBSCT in 71 leukaemic patients (a single centre study)
    Iravani, M
    Tavakoli, M
    Shamshiri, AR
    Evazi, MR
    Mousavi, A
    Bahar, B
    Ghavamzadeh, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S218 - S219
  • [7] Prospective validation of novel myeloablative conditioning regimen:Fludarabine-IV Busulfan in 38 patients with acute myeloid leukaemia
    Talbi, A.
    Hamladji, R. M.
    Benakli, M.
    Ahmed-Nacer, R.
    Belhadj, R.
    Mehdid, F.
    Rahmoune, N.
    Harieche, F.
    Zerhouni, F.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S78 - S78
  • [8] Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience
    Memoli, Mara
    Paviglianiti, Annalisa
    Malard, Florent
    Battipaglia, Giorgia
    Brissot, Eolia
    Mediavilla, Clemence
    Bianchessi, Antonio
    Banet, Anne
    Van de Wyngaert, Zoe
    Ledraa, Tounes
    Belhocine, Ramdane
    Sestili, Simona
    Lapusan, Simona
    Hirsch, Pierre
    Favale, Fabrizia
    Boussaroque, Agathe
    Bonnin, Agnes
    Vekhoff, Anne
    Legrand, Ollivier
    Mohty, Mohamad
    Dulery, Remy
    LEUKEMIA & LYMPHOMA, 2021, 62 (02) : 419 - 427
  • [9] IV BUSULFAN AND FLUDARABINE (BUXFLU) AS TRANSPLANT CONDITIONING REGIMEN IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS: ANALYSIS OF A SINGLE CENTRE EXPERIENCE
    Rodriguez Macias, G.
    Munoz, C.
    Serrano, D.
    Gayoso, J.
    Balsalobre, P.
    Buno, I.
    Encinas, C.
    Gomez-Pineda, A.
    Diez-Martin, J. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 469 - 469
  • [10] Busulfan-fludarabine as myeloablative conditioning regimen in allogeneic stem cell transplantation: incidence of complications and outcome. A single-centre experience
    Parma, M.
    Pioltelli, P.
    Terruzzi, E.
    Bozzani, S.
    Pogliani, E.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S94 - S94
12345